EquityFlowCompanies › Molmir

Molmir

Biotech · JP

Piattaforma di drug discovery che visualizza la dinamica delle molecole (CHEmir, MAGmir) per bersagli finora intrattabili.

Funding history

DateRoundAmount
Apr 2026Series A
Molmir raised 300 million yen in Series A funding from UntroD, Mitsubishi UFJ Capital and others for its molecular dynamics analysis platform and the TDP-43 program.
$1.9M

Investors

BP CapitalHigin CapitalIkeda Senshu CapitalMitsubishi UFJ CapitalNanto Capital PartnersUntroD Capital Japan

Similar companies in Biotech

Explore funding flow on EquityFlow →